News Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
52.79 ^USD	+0.98%		+8.82%	-36.77%

10:07pm	Cytokinetics Insider Sold Shares Worth $1,099,125, According to a Recent SEC Filing	MT
Jun. 05	Sector Update: Health Care Stocks Advance Late Afternoon	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytokinetics Insider Sold Shares Worth $1,099,125, According to a Recent SEC Filing	04:07pm	MT
Sector Update: Health Care Stocks Advance Late Afternoon	Jun. 05	MT
Sector Update: Health Care Stocks Rise Wednesday Afternoon	Jun. 05	MT
Sector Update: Health Care	Jun. 05	MT
Cytokinetics Says Third Party Dropped Takeover Bid Despite Negotiations; Shares Rise	Jun. 05	MT
Cytokinetics CEO Says Board Would Have Backed Actionable Buyout	Jun. 05	DJ
Cytokinetics Incorporated : Regulation FD Presentation Form 8 K	Jun. 05	PU
Cytokinetics Says Third Party Did Not Move Forward with Acquisition After Talks	Jun. 04	CI
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Jun. 04	AQ
B. Riley Cuts Price Target on Cytokinetics to $92 From $122, Maintains Buy Rating	Jun. 04	MT
Cytokinetics Insider Sold Shares Worth $635,978, According to a Recent SEC Filing	Jun. 03	MT
Cytokinetics to Participate in June Investor Conferences	May. 29	AQ
Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating	May. 29	MT
Cytokinetics Closes $500 Million Stock Offering	May. 28	MT
Cytokinetics Announces Closing of Public Offering of Common Stock	May. 28	AQ
JMP Securities Adjusts Cytokinetics Price Target to $78 From $106, Maintains Market Outperform Rating	May. 28	MT
Cytokinetics, Incorporated announced that it has received $49.999992 million in funding from Royalty Pharma Development Funding, LLC	May. 27	CI
Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating	May. 23	MT
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday	May. 23	MT
Nvidia Earnings Fuel Investor Optimism, Driving Premarket Gains for US Equity Futures	May. 23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Summary

Filters